Olympia Pharmacy Recalls Atropine Sulfate Injection Due to Sterility Concerns
Olympia Pharmacy is recalling Atropine Sulfate 50 mg/ml Injection due to FDA inspection findings regarding quality control and lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II. According to the rubric, an FDA Class II recall involving a significant hazard such as lack of sterility in an injectable drug corresponds to a Severe (4) rating.
Plain-English summary
Lowlite Investments, Inc. D/B/A Olympia Pharmacy is recalling Atropine Sulfate 50 mg/ml Injection. The recall was initiated following FDA inspection findings that raised concerns regarding the quality control processes used during the compounding of the product.
The specific hazard identified is a lack of assurance of sterility. The affected product is identified by the code C5115 with an expiration date of 9/11/13. The recall number is D-702-2013.
The product was distributed nationwide and in Puerto Rico. Consumers and healthcare providers should stop using the recalled product and contact their pharmacist or the recalling firm for further instructions.
The recalled product
- Product
- Atropine Sulfate 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
- Manufacturer
- Lowlite Investments, Inc. D/B/A Olympia Pharmacy
- Category
- Drug — Injectable
- Hazard
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- C5115 Exp 9/11/13
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 105 recalled by Lowlite Investments, Inc. D/B/A Olympia Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 105 products in this recall →Related recalls
Same manufacturer · Lowlite Investments, Inc. D/B/A Olympia Pharmacy
See all →- SevereOlympia Pharmacy Recalls Diclazuril Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- HighOlympia Pharmacy Recalls Metabolase Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- SevereOlympia Pharmacy Recalls Oxytocin Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- SevereOlympia Pharmacy Recalls Betamethasone Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- SevereOlympia Pharmacy Recalls HACC 270.1 Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- HighFDA Recalls Sodium Tetradecyl Sulfate Injectable Over Sterility Assurance Failure
FDA (Drugs) · 2022-06-01
- HighFDA Recalls Sodium Tetradecyl Sulfate Injection Due to Sterility Assurance Failure
FDA (Drugs) · 2022-06-01
- SeverePharmedium Recalls Atropine Sulfate Injection Due to Sterility Concerns
FDA (Drugs) · 2018-02-28
- HighFormula F2 Compounded Injectable Medication Recalled for Sterility Assurance Failure
FDA (Drugs) · 2022-06-01
- SevereKey Pharmacy Recalls Atropine Sulfate Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- HighCompounded Injectable Drug Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2022-06-01